financial
financial

Nestlé to Acquire Dermatology Assets for $1.4 Billion

The Swiss giant is buying the rights to commercialize some products from Valeant Pharmaceuticals International in the U.S. and Canada.

financial/news
News from WWD
Newsletters

Sign upSign up for WWD and FN newsletters to receive daily headlines, breaking news alerts and weekly industry wrap-ups.

LatestPublications
getIsArchiveOnly= hasAccess=false hasArchiveAccess=false